Marker Therapeutics Reports Year-End 2023 Corporate and
Lead program in patients with lymphoma demonstrated preliminary safety and efficacy results with sustained complete response in first study participant...
United States Lincoln Park Daniel Kontoh Boateng Juan Vera International Nonproprietary Names Small Business Innovation Research
Source: globenewswire.com